Corey S Davis
Biographic Data
| ID | 6056269 |
|---|---|
| NAME | Corey S Davis |
| GIVEN NAMES | Corey S |
| FAMILY NAME | Davis |
| SIGNATURE | DAVIS C S |
| AFFILIATIONS | National Health Law Program |
| ORCID | 0000-0002-6278-5013 |
| VERIFIED | Yes |
| TOTAL WORKS | 36 |
| TOTAL CITATIONS | 43 |
| WORKS AS AUTHOR | 36 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2005 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 4 |
A comprehensive review of state laws that govern the distribution and possession of drug use equipment in the United States
Examining the association between county racialised economic segregation and fatal overdose in US counties, 2018–2022
Background Between 2022 and 2023, overdose mortality decreased among non-Hispanic (NH) white people but stayed the same or increased among people of colour in the USA. County racialised economic segregation may contribute to overdose mortality. Methods We used a Bayesian spatiotemporal approach to assess the association between racialised economic segregation quintile and overdose deaths (overall and race-stratified) in 3133 US counties from 2018…
How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013–2020? An application of a new state opioid poli…
The relationship of medical and recreational cannabis laws with opioid misuse and opioid use disorder in the USA
Comparing individuals in MCL alone states to those in states without such laws, we found an inconsistent pattern of decreased odds of opioid outcomes, which were more pronounced among people reporting cannabis use. The pattern did not hold for individuals in RCL states. In line with a substitution-oriented perspective, findings suggests that MCLs may be associated with reductions in opioid use among people using cannabis but additional work to re…
A call for compassionate opioid overdose response
High dose and long-acting opioid overdose reversal drugs can precipitate withdrawal in people who are opioid dependent. Products recently brought to market for community use in the United States (US) have drawn international concern because of their increased risk of withdrawal. At the March 18-19, 2024, Compassionate Overdose Response Summit & Naloxone Dosing Meeting, a panel of harm reduction experts issued the following call to action: 1) peop…
User Engagement Testing with a Pilot Decision Support Tool Aimed to Support Species Managers
Species status assessments (SSAs) are required for endangered species by the U.S. Fish and Wildlife Service and focus on the resiliency, redundancy, and representation of endangered species. SSAs must include climate information, because climate is a factor that will impact species in the future. To aid in the inclusion of climate information, a decision support system (DSS) entitled Climate Analysis and Visualization for the Assessment of Specie…
Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment
In this cross-sectional study of US pharmacy claims, state-mandated educational requirements beyond the initial training required to prescribe buprenorphine were associated with increased buprenorphine use over time. The findings suggest requiring education for buprenorphine prescribers and training in substance use disorder treatment for all controlled substance prescribers as an actionable proposal for increasing buprenorphine use, ultimately s…
Typology of laws restricting access to methadone treatment in the United States
States with indicators of greater potential need for opioid use disorder treatment have the most restrictions, raising concerns about unmet treatment need
Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use
Changes in arrests following decriminalization of low-level drug possession in Oregon and Washington
This analysis demonstrates that it is possible for state drug decriminalization policies to dramatically reduce arrests for drug possession without increasing arrests for violent crimes, potentially reducing harm to people who use drugs and their communities. Additional research is needed to determine whether these legal reforms were associated with changes in overdose rates and other drug-related harms
Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019
In 2017, Rhode Island responded to rising overdose deaths by establishing statewide emergency department (ED) treatment standards for opioid overdose and opioid use disorder. One requirement of the policy is that providers prescribe or provide take-home naloxone to anyone presenting to EDs with opioid overdose. Among adults presenting to EDs with opioid overdose from 2018 to 2019, approximately half received take-home naloxone. Receipt of naloxon…
Persistent Criminalization and Structural Racism in US Drug Policy
The US overdose crisis continues to worsen and is disproportionately harming Black and Hispanic/Latino people. Although the “War on Drugs” continues to shape drug policy—at the disproportionate expense of Black and Hispanic/Latino people—states have taken some steps to reduce War on Drugs–related harms and adopt a public health–centered approach. However, the rhetoric regarding these changes has, in many cases, outstripped reality. Using overdose…
Association Between State Opioid Prescribing Cap Laws and Receipt of Opioid Prescriptions Among Children and Adolescents
In this cross-sectional study, no association was observed between state opioid prescribing cap laws and the receipt of opioid prescriptions among children and adolescents. Alternative strategies, such as opioid prescribing guidelines tailored to youths, are needed
A modified Delphi process to identify experts’ perceptions of the most beneficial and harmful laws to reduce opioid-related harm
Principles and Metrics for Evaluating Oregon’s Innovative Drug Decriminalization Measure
Harm Reduction, By Mail
Continuing increased access to buprenorphine in the United States via telemedicine after Covid-19
Good Samaritan laws and overdose mortality in the United States in the fentanyl era
Reducing Opioid Overdose Deaths by Expanding Naloxone Distribution and Addressing Structural Barriers to Care
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid Covid-19 and Beyond
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond Brian S. Barnett MD, Sarah E. Wakeman MD, Corey S. Davis JD, MSPH, Jamie Favaro MSW, and Josiah D. Rich MD, MPH Affiliation Brian S. Barnett is with the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH. Sarah E. Wakeman is with the Division of General Internal Medicine, Ma…
Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014–2018
Objectives. To examine early impacts of laws that require naloxone to be prescribed to patients at increased overdose risk. Methods. Using data from 2014 to 2018 from a large pharmacy chain, CVS Pharmacy, we examined the effects of naloxone-prescribing mandates 90 days before and after they took effect in Arizona, Florida, Rhode Island, Vermont, and Virginia. We compared the number of naloxone doses initiated directly by prescribers and by pharma…
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning
Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States
Bias Against People Who Inject Drugs Undermines Police Training on Needlestick Injury
"Bias Against People Who Inject Drugs Undermines Police Training on Needlestick Injury." , 109(6), pp. 839–840
Paraphernalia Laws, Criminalizing Possession and Distribution of Items Used to Consume Illicit Drugs, and Injection-Related Harm
The United States remains in the grip of an unprecedented epidemic of drug-related harm. Infections of HIV, hepatitis C, and endocarditis related to lack of access to new syringes and subsequent syringe sharing among people who inject drugs have increased alongside a surge in opioid overdose deaths. Overwhelming evidence shows that using a new syringe with every injection prevents injection-related blood-borne disease transmission. Additionally, …
Effects of an Intensive Street-Level Police Intervention on Syringe Exchange Program Use in Philadelphia, Pa
Repeated measurements and mixed-effects models were used to analyze the effects of an intensive long-term street-level police intervention on syringe exchange program use. Utilization data for 9 months before and after the beginning of the intervention were analyzed. Use fell across all categories and time periods studied, with significant declines in use among total participants, male participants, and Black participants. Declines in use among B…
Expanded Access to Naloxone Among Firefighters, Police Officers, and Emergency Medical Technicians in Massachusetts
Naloxone is a medication that reverses respiratory depression from opioid overdose if given in time. Paramedics routinely administer naloxone to opioid overdose victims in the prehospital setting, and many states are moving to increase access to the medication. Several jurisdictions have expanded naloxone administration authority to nonparamedic first responders, and others are considering that step. We report here on policy change in Massachuset…
The Law (and Politics) of Safe Injection Facilities in the United States
Safe injection facilities (SIFs) have shown promise in reducing harms and social costs associated with injection drug use. Favorable evaluations elsewhere have raised the issue of their implementation in the United States. Recognizing that laws shape health interventions targeting drug users, we analyzed the legal environment for publicly authorized SIFs in the United States. Although states and some municipalities have the power to authorize SIF…
Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014–2018
Objectives. To examine early impacts of laws that require naloxone to be prescribed to patients at increased overdose risk. Methods. Using data from 2014 to 2018 from a large pharmacy chain, CVS Pharmacy, we examined the effects of naloxone-prescribing mandates 90 days before and after they took effect in Arizona, Florida, Rhode Island, Vermont, and Virginia. We compared the number of naloxone doses initiated directly by prescribers and by pharma…
Principles and Metrics for Evaluating Oregon’s Innovative Drug Decriminalization Measure
Persistent Criminalization and Structural Racism in US Drug Policy
The US overdose crisis continues to worsen and is disproportionately harming Black and Hispanic/Latino people. Although the “War on Drugs” continues to shape drug policy—at the disproportionate expense of Black and Hispanic/Latino people—states have taken some steps to reduce War on Drugs–related harms and adopt a public health–centered approach. However, the rhetoric regarding these changes has, in many cases, outstripped reality. Using overdose…
Paraphernalia Laws, Criminalizing Possession and Distribution of Items Used to Consume Illicit Drugs, and Injection-Related Harm
The United States remains in the grip of an unprecedented epidemic of drug-related harm. Infections of HIV, hepatitis C, and endocarditis related to lack of access to new syringes and subsequent syringe sharing among people who inject drugs have increased alongside a surge in opioid overdose deaths. Overwhelming evidence shows that using a new syringe with every injection prevents injection-related blood-borne disease transmission. Additionally, …
Engaging Law Enforcement in Overdose Reversal Initiatives
Opioid overdose is reversible through the timely administration of naloxone, which has been used by emergency medical services for decades. Law enforcement officers (LEOs) are often the first emergency responders to arrive at an overdose, but they are not typically equipped with naloxone. This is rapidly changing; more than 220 law enforcement agencies in 24 states now carry naloxone. However, rollout in some departments has been hampered by conc…
Evolution and Convergence of State Laws Governing Controlled Substance Prescription Monitoring Programs, 1998-2011
Objectives. We sought to collect and characterize all laws governing the operation of prescription monitoring programs (PMPs), state-level databases that collect patient-specific prescription information, which have been suggested as a tool for reducing prescription drug overdose fatalities. Methods. We utilized a structured legal research protocol to systematically identify, review, and code all PMP statutes and regulations effective from 1998 t…
Examining the association between county racialised economic segregation and fatal overdose in US counties, 2018–2022
Background Between 2022 and 2023, overdose mortality decreased among non-Hispanic (NH) white people but stayed the same or increased among people of colour in the USA. County racialised economic segregation may contribute to overdose mortality. Methods We used a Bayesian spatiotemporal approach to assess the association between racialised economic segregation quintile and overdose deaths (overall and race-stratified) in 3133 US counties from 2018…
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid Covid-19 and Beyond
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond Brian S. Barnett MD, Sarah E. Wakeman MD, Corey S. Davis JD, MSPH, Jamie Favaro MSW, and Josiah D. Rich MD, MPH Affiliation Brian S. Barnett is with the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH. Sarah E. Wakeman is with the Division of General Internal Medicine, Ma…
Status of US State Laws Mandating Timely Reporting of Nonfatal Overdose
Effects of an Intensive Street-Level Police Intervention on Syringe Exchange Program Use in Philadelphia, Pa
Repeated measurements and mixed-effects models were used to analyze the effects of an intensive long-term street-level police intervention on syringe exchange program use. Utilization data for 9 months before and after the beginning of the intervention were analyzed. Use fell across all categories and time periods studied, with significant declines in use among total participants, male participants, and Black participants. Declines in use among B…
The Law (and Politics) of Safe Injection Facilities in the United States
Safe injection facilities (SIFs) have shown promise in reducing harms and social costs associated with injection drug use. Favorable evaluations elsewhere have raised the issue of their implementation in the United States. Recognizing that laws shape health interventions targeting drug users, we analyzed the legal environment for publicly authorized SIFs in the United States. Although states and some municipalities have the power to authorize SIF…
Expanded Access to Naloxone Among Firefighters, Police Officers, and Emergency Medical Technicians in Massachusetts
Naloxone is a medication that reverses respiratory depression from opioid overdose if given in time. Paramedics routinely administer naloxone to opioid overdose victims in the prehospital setting, and many states are moving to increase access to the medication. Several jurisdictions have expanded naloxone administration authority to nonparamedic first responders, and others are considering that step. We report here on policy change in Massachuset…
Evolution and Convergence of State Laws Governing Controlled Substance Prescription Monitoring Programs, 1998-2011
Objectives. We sought to collect and characterize all laws governing the operation of prescription monitoring programs (PMPs), state-level databases that collect patient-specific prescription information, which have been suggested as a tool for reducing prescription drug overdose fatalities. Methods. We utilized a structured legal research protocol to systematically identify, review, and code all PMP statutes and regulations effective from 1998 t…
Overdose Epidemic, Prescription Monitoring Programs, and Public Health
Prescription monitoring programs (PMPs), state-level databases that collect patient-specific prescription information at the time medications are dispensed, have been suggested as tools to address the overdose epidemic. We reviewed all laws in the United States (n = 25) that articulated the purposes PMPs are intended to serve. Attributes related to reducing abuse, misuse, and diversion of prescription medications appeared most commonly. Only 5 pu…
Engaging Law Enforcement in Overdose Reversal Initiatives
Opioid overdose is reversible through the timely administration of naloxone, which has been used by emergency medical services for decades. Law enforcement officers (LEOs) are often the first emergency responders to arrive at an overdose, but they are not typically equipped with naloxone. This is rapidly changing; more than 220 law enforcement agencies in 24 states now carry naloxone. However, rollout in some departments has been hampered by conc…
Today’s fentanyl crisis
Opioid-overdose laws association with opioid use and overdose mortality
From Peers to Lay Bystanders
Distribution of the opioid overdose reversal drug naloxone has been central to efforts to combat the ongoing opioid epidemic in the United States. This report presents data from Prevention Point Pittsburgh (PPP), a public health advocacy and direct service organization that has operated an overdose prevention program (OPP) with naloxone distribution since 2005. The program initially provided naloxone training and distribution only to people who u…
Status of US State Laws Mandating Timely Reporting of Nonfatal Overdose
Prescription drug monitoring programs operational characteristics and fatal heroin poisoning
Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States
Bias Against People Who Inject Drugs Undermines Police Training on Needlestick Injury
"Bias Against People Who Inject Drugs Undermines Police Training on Needlestick Injury." , 109(6), pp. 839–840
Paraphernalia Laws, Criminalizing Possession and Distribution of Items Used to Consume Illicit Drugs, and Injection-Related Harm
The United States remains in the grip of an unprecedented epidemic of drug-related harm. Infections of HIV, hepatitis C, and endocarditis related to lack of access to new syringes and subsequent syringe sharing among people who inject drugs have increased alongside a surge in opioid overdose deaths. Overwhelming evidence shows that using a new syringe with every injection prevents injection-related blood-borne disease transmission. Additionally, …
Davis et al. Respond
AffiliationsCorey S. Davis, Hector Hernandez-Delgado, and Amy Judd Lieberman are with the Network for Public Health Law, Los Angeles, CA. Traci C. Green is with Boston University School of Medicine, Boston, MA, and the Warren Alpert School of Medicine of Brown University, Providence, RI
Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014–2018
Objectives. To examine early impacts of laws that require naloxone to be prescribed to patients at increased overdose risk. Methods. Using data from 2014 to 2018 from a large pharmacy chain, CVS Pharmacy, we examined the effects of naloxone-prescribing mandates 90 days before and after they took effect in Arizona, Florida, Rhode Island, Vermont, and Virginia. We compared the number of naloxone doses initiated directly by prescribers and by pharma…
Harm Reduction, By Mail
Continuing increased access to buprenorphine in the United States via telemedicine after Covid-19
Good Samaritan laws and overdose mortality in the United States in the fentanyl era
Reducing Opioid Overdose Deaths by Expanding Naloxone Distribution and Addressing Structural Barriers to Care
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid Covid-19 and Beyond
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond Brian S. Barnett MD, Sarah E. Wakeman MD, Corey S. Davis JD, MSPH, Jamie Favaro MSW, and Josiah D. Rich MD, MPH Affiliation Brian S. Barnett is with the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH. Sarah E. Wakeman is with the Division of General Internal Medicine, Ma…
Association Between State Opioid Prescribing Cap Laws and Receipt of Opioid Prescriptions Among Children and Adolescents
In this cross-sectional study, no association was observed between state opioid prescribing cap laws and the receipt of opioid prescriptions among children and adolescents. Alternative strategies, such as opioid prescribing guidelines tailored to youths, are needed
A modified Delphi process to identify experts’ perceptions of the most beneficial and harmful laws to reduce opioid-related harm
Principles and Metrics for Evaluating Oregon’s Innovative Drug Decriminalization Measure
User Engagement Testing with a Pilot Decision Support Tool Aimed to Support Species Managers
Species status assessments (SSAs) are required for endangered species by the U.S. Fish and Wildlife Service and focus on the resiliency, redundancy, and representation of endangered species. SSAs must include climate information, because climate is a factor that will impact species in the future. To aid in the inclusion of climate information, a decision support system (DSS) entitled Climate Analysis and Visualization for the Assessment of Specie…
Opioid Use Disorder Treatment (31 works) · Medicine (29 works) · Law (19 works) · Political science (19 works) · HIV, Drug Use, Sexual Risk (17 works) · Opioid (17 works) · Psychiatry (13 works) · Substance Abuse Treatment and Outcomes (13 works) · Medical emergency (12 works) · Psychology (11 works)